Why ArQule Was Chopped In Half


ArQule (Nasdaq: ARQL  ) shares are down 55% today after the company stopped a phase 3 trial for its lung cancer drug ARQ-197. This is the second issue for ArQule's lead drug candidate, with a previous trial halted because of safety-related problems. The good news here is that the drug does in fact appear to be safe. Unfortunately, it doesn't appear any more effective than placebo in treating lung cancer. Without any other drugs on the market, ArQule is just lucky that the crash isn't worse.

Peregrine Pharmaceuticals (Nasdaq: PPHM  ) recently lost 80% of its value after being forced to throw out its lung cancer trial data. ArQule will try its own drug across other cancer types, which makes sense since plenty of approved drugs work for some conditions and not others. It's a huge setback for Peregrine, but fortunately the company has two years' worth of cash at its current burn rate, so investors aren't at risk for dilution.

While you can make huge gains in biotech and pharmaceuticals, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, and also reveal some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.

Dave Williamson has no positions in the stocks mentioned above. Max Macaluso has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2040888, ~/Articles/ArticleHandler.aspx, 4/21/2014 8:40:19 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement